A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1994
11/24/1994	CA2162272A1 Vitamin d amide derivatives
11/24/1994	CA2162022A1 Processes for producing an enzyme
11/24/1994	CA2161797A1 Xenograft thymus
11/24/1994	CA2161334A1 Hiv protease inhibitors useful in the treatment of aids
11/24/1994	CA2161021A1 Thioindole pyperidinyl derivatives used as antalgics
11/24/1994	CA2160786A1 Ras farnesyl transferase inhibitors
11/24/1994	CA2160124A1 Optically active 3-(1-(alkylamino)) alkyl pyrrolidines
11/24/1994	CA2159728A1 Synthetic aglucodalbaheptide antibiotics
11/23/1994	EP0625204A1 Hepatitis therapeutics
11/23/1994	EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine
11/23/1994	EP0625194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide.
11/23/1994	EP0625192A1 Nucleozymes
11/23/1994	EP0625160A1 Leukinferon preparation
11/23/1994	EP0625158A1 Therapeutic nucleosides
11/23/1994	EP0625150A1 1,3-oxathiolane nucleoside analogues
11/23/1994	EP0625053A1 Urease-based vaccine against helicobacter infection
11/23/1994	EP0625052A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
11/23/1994	EP0625043A1 Recombinant multivalent m protein vaccine
11/23/1994	EP0545966B1 New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs
11/23/1994	CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/22/1994	US5366989 Triazole derivatives and salts thereof and antifungal agent containing the same
11/22/1994	US5366890 Alkaloids from cultures
11/22/1994	US5366505 Method of reducing medical device related infections
11/22/1994	CA1333150C Method for the control of pneumocystis carinii
11/18/1994	CA2123921A1 Polypeptide compound and a process for preparation thereof
11/17/1994	EP0624586A1 Substituted pyrroles
11/17/1994	EP0624376A1 Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
11/17/1994	EP0624372A2 Medicament for treating human immunodeficiency virus
11/17/1994	EP0624368A2 Use of a composition for stimulating the synthesis of glutathione in the manufacture of a medicament for the treatment of acquired immune deficiency syndrome
11/17/1994	EP0624198A1 Synthetic peptides for a rubella vaccine
11/17/1994	EP0624162A1 Novel steroid intermediates and processes for their preparation
11/17/1994	EP0624161A1 2'-desoxy-isoguanosines, isoster analogues and isoguanosine derivates and their use
11/17/1994	EP0624160A1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
11/17/1994	EP0624159A1 Pyridyl substituted imidazoles
11/17/1994	EP0624089A1 Methods
11/17/1994	EP0605704A4 Starch-iodine-peroxide preservation of blood, tissues and biological fluids.
11/16/1994	CN1095106A Vaccines
11/16/1994	CN1095069A Novel process
11/16/1994	CN1095068A Bicyclic amine derivatives
11/15/1994	US5364938 Triazole antifungal agents
11/15/1994	US5364931 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type
11/15/1994	US5364865 Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
11/15/1994	US5364774 Isolation of polynucleotides like DNA, hybridization and degeneration
11/15/1994	US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus
11/13/1994	CA2123261A1 Urethanes and ureas that induce cytokine production
11/11/1994	CA2122814A1 Method for treating acquired immune deficiency syndrome
11/11/1994	CA2121567A1 Substituted pyrroles
11/10/1994	WO1994025602A1 Hepatitis-c virus type 4, 5 and 6
11/10/1994	WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	WO1994025599A1 Mammal cell lines and method of obtaining glycoproteins
11/10/1994	WO1994025596A2 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
11/10/1994	WO1994025477A2 Novel peptide nucleic acids
11/10/1994	WO1994025465A1 SUBSTITUTED METHYLENEDIOXY[3',4':6,7]INDOLIZINO-[1,2-b]QUINOLINONES
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025050A1 Cyclohexapeptidyl propanolamine compounds
11/10/1994	WO1994025048A1 Cyclohexapeptidyl amine compounds
11/10/1994	WO1994025046A1 Method of combating acyclovir-resistant herpes simplex viral infections
11/10/1994	WO1994025045A1 Cyclohexapeptidyl aminoalkyl ethers
11/10/1994	WO1994025037A1 Anti-viral guanosine-rich oligonucleotides
11/10/1994	WO1994021812A3 Hepatitis b escape mutant specific binding molecules
11/10/1994	CA2662090A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	CA2161980A1 Substituted methylenedioxy¬3',4':6,7\|indolizino-¬1,2-b\|quinolinones
11/10/1994	CA2161534A1 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
11/10/1994	CA2161517A1 Mammalian cell lines and method of obtaining glycoproteins
11/10/1994	CA2161243A1 Antiviral guanosine-rich oligonucleotides
11/10/1994	CA2161230A1 Novel peptide nucleic acids
11/10/1994	CA2161150A1 Cyclohexapeptidyl propanolamine compounds
11/10/1994	CA2161149A1 Cyclohexapeptidyl aminoalkyl ethers
11/10/1994	CA2159835A1 Cyclohexapeptidyl amine compounds
11/09/1994	EP0623605A2 Substituted piperazines as antiretroviral medicaments
11/09/1994	EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors
11/09/1994	EP0623172A1 Marek's disease virus recombinant poxvirus vaccine
11/09/1994	EP0623170A1 Vaccines based on streptokinase
11/09/1994	EP0623169A1 Hepatitis e virus vaccine and method
11/09/1994	EP0623167A1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
11/09/1994	EP0623147A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus
11/09/1994	EP0623136A1 Novel cephalosporin compounds
11/09/1994	EP0623133A1 Substituted amino alkyl compounds
11/09/1994	EP0623130A1 Antibacterial 1-normon-2-yl thiazolyl ketones
11/09/1994	EP0623126A1 Imidazole derivatives and their use as cytokine inhibitors
11/09/1994	EP0623026A1 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera
11/09/1994	EP0623021A1 4''-deoxyerythromycin derivatives
11/09/1994	EP0623020A1 Pyropheophorbides and their use in photodynamic therapy
11/09/1994	EP0152477B1 Polypeptide-induced monoclonal antibodies to oncoproteins
11/09/1994	CN1094729A C-11 modified prodimicin derivatives
11/09/1994	CN1094728A Process for preparing carbapenen and penem compounds and new compounds involved in that process
11/09/1994	CN1094642A Therapeutic combination
11/09/1994	CN1094640A Urease-based vaccine against helicobacter infection
11/09/1994	CN1026489C Antirhinoviral (thio) morpholinyl and piperazinyl alkylphenol ethers
11/08/1994	US5362724 Antibiotics as bactericides
11/08/1994	US5362722 Cephalosporin antibacterial agents
11/08/1994	US5362718 Antibody inhibitors, antiinflammatory agents, fungicides, antitumor agents
11/08/1994	CA1332941C N-alkylated quaternary nitrogen containing heterocycles
11/08/1994	CA1332940C N-alkylated quaternary nitrogen-containing heterocycles
11/08/1994	CA1332939C 2,5,6-substituted-n -alkylpyrimidines
11/08/1994	CA1332938C N-alkylated quaternary nitrogen-containing heterocycles
11/08/1994	CA1332919C Viral vaccine
11/07/1994	CA2122787A1 Substituted piperazines
11/04/1994	CA2095408A1 Method of combating acyclovir-resistant herpes simplex viral infections
11/02/1994	EP0622375A1 Chrysospermines, peptide drugs from Apiocrea chrysosperma having pharmacological activity, process for their production, and their use

1 ... 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 ... 1798